- Report
- October 2023
- 146 Pages
Global
From €3244EUR$3,320USD£2,708GBP
€4055EUR$4,150USD£3,385GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2687EUR$2,750USD£2,243GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3420EUR$3,500USD£2,855GBP
- Report
- July 2024
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- April 2024
- 132 Pages
Global
From €928EUR$950USD£775GBP
- Report
- April 2023
- 400 Pages
Global
From €3605EUR$3,690USD£3,010GBP
- Report
- December 2021
- 159 Pages
Global
From €3627EUR$3,712USD£3,028GBP
- Book
- April 2015
- 352 Pages
- Book
- May 2018
North America
The In Vitro Diagnostics (IVD) Virus Test market is a subset of the larger IVD market, which focuses on the development and production of tests used to detect viruses. These tests are used to diagnose and monitor the presence of viruses in a patient's body, and can be used to detect a wide range of viruses, including those that cause the common cold, influenza, and other respiratory illnesses.
The IVD Virus Test market is highly competitive, with a variety of companies offering different types of tests. These tests range from rapid antigen tests to more complex molecular tests, such as PCR tests. Companies in the market are also developing tests for emerging viruses, such as Zika and Ebola.
Some of the major companies in the IVD Virus Test market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies are at the forefront of developing and producing tests for a variety of viruses, and are constantly innovating to provide the most accurate and reliable tests available. Show Less Read more